HK1214596A1 - 經取代噻唑基乙酸三乙胺鹽的結晶型 - Google Patents
經取代噻唑基乙酸三乙胺鹽的結晶型Info
- Publication number
- HK1214596A1 HK1214596A1 HK16102556.4A HK16102556A HK1214596A1 HK 1214596 A1 HK1214596 A1 HK 1214596A1 HK 16102556 A HK16102556 A HK 16102556A HK 1214596 A1 HK1214596 A1 HK 1214596A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- crystalline form
- triethylamine salt
- acid triethylamine
- substituted
- thiazolylacetic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
- C07D277/593—Z being doubly bound oxygen or doubly bound nitrogen, which nitrogen is part of a possibly substituted oximino radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361779091P | 2013-03-13 | 2013-03-13 | |
| PCT/US2014/021080 WO2014164187A1 (en) | 2013-03-13 | 2014-03-06 | Crystalline form of a substituted thiazolylacetic acid triethylamine salt |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1214596A1 true HK1214596A1 (zh) | 2016-07-29 |
Family
ID=50382685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16102556.4A HK1214596A1 (zh) | 2013-03-13 | 2016-03-07 | 經取代噻唑基乙酸三乙胺鹽的結晶型 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9139542B2 (zh) |
| EP (1) | EP2970164B1 (zh) |
| JP (2) | JP6404309B2 (zh) |
| KR (1) | KR20150126368A (zh) |
| CN (1) | CN105121417B (zh) |
| AU (1) | AU2014249611B2 (zh) |
| BR (1) | BR112015022600A2 (zh) |
| CA (1) | CA2902724A1 (zh) |
| EA (1) | EA027911B1 (zh) |
| ES (1) | ES2634019T3 (zh) |
| GE (1) | GEP201706779B (zh) |
| HK (1) | HK1214596A1 (zh) |
| IL (1) | IL240600A0 (zh) |
| MD (1) | MD4719C1 (zh) |
| MX (1) | MX351963B (zh) |
| PH (1) | PH12015502067A1 (zh) |
| SG (1) | SG11201507221VA (zh) |
| TW (1) | TWI627165B (zh) |
| UA (1) | UA115087C2 (zh) |
| WO (1) | WO2014164187A1 (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021014751A (es) * | 2019-05-31 | 2022-01-18 | Hyundai Pharm Co Ltd | Forma cristalina novedosa de derivado de acido 3-(4-(benciloxi)fenil)hex-4-inoico. |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4372952A (en) | 1978-07-31 | 1983-02-08 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| US4284631A (en) | 1978-07-31 | 1981-08-18 | Fujisawa Pharmaceutical Co., Ltd. | 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them |
| US4341775A (en) | 1978-09-11 | 1982-07-27 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| GB2033377B (en) | 1978-09-11 | 1983-05-05 | Fujisawa Pharmaceuticalco Ltd | Cephem compounds and processes for preparation thereof |
| US4220761A (en) | 1978-09-12 | 1980-09-02 | Fujisawa Pharmaceutical Co., Ltd. | 7-[Substituted oximinoacetamido]-3-[hydroxy alkyltetrazolo]cephalosporin derivatives |
| DE2945248A1 (de) | 1978-11-13 | 1980-05-22 | Fujisawa Pharmaceutical Co | Cephem-verbindungen, verfahren zu ihrer herstellung und sie enthaltende antibakterielle pharmazeutische mittel |
| DE3177090D1 (en) * | 1980-12-31 | 1989-09-28 | Fujisawa Pharmaceutical Co | 7-acylaminocephalosporanic acid derivatives and processes for the preparation thereof |
| JP2519054B2 (ja) | 1986-06-09 | 1996-07-31 | 武田薬品工業株式会社 | 新規セフェム化合物 |
| AU1630988A (en) | 1987-05-30 | 1988-12-01 | Kyoto Pharmaceutical Industries, Ltd. | Cephalosporin compound and pharmaceutical composition thereof |
| JPH04221388A (ja) * | 1990-12-20 | 1992-08-11 | Asahi Chem Ind Co Ltd | セファロスポリン化合物およびその製造法 |
| TWI335332B (en) * | 2001-10-12 | 2011-01-01 | Theravance Inc | Cross-linked vancomycin-cephalosporin antibiotics |
| ITMI20012363A1 (it) | 2001-11-09 | 2003-05-09 | Antibioticos Spa | Metodo per la sintesi di catene laterali di cefalosporine |
| ES2384707T3 (es) | 2002-05-24 | 2012-07-11 | Theravance, Inc. | Antibióticos entrecruzados de glucopéptidos y cefalosporinas |
| GB0416379D0 (en) | 2004-07-22 | 2004-08-25 | Sandoz Ag | Organic compounds |
| TW200637559A (en) | 2005-03-29 | 2006-11-01 | Shionogi & Co | 3-propenylcefem derivative |
-
2014
- 2014-03-06 EP EP14712945.6A patent/EP2970164B1/en active Active
- 2014-03-06 JP JP2016500718A patent/JP6404309B2/ja active Active
- 2014-03-06 ES ES14712945.6T patent/ES2634019T3/es active Active
- 2014-03-06 SG SG11201507221VA patent/SG11201507221VA/en unknown
- 2014-03-06 EA EA201591708A patent/EA027911B1/ru unknown
- 2014-03-06 CA CA2902724A patent/CA2902724A1/en not_active Abandoned
- 2014-03-06 MX MX2015012146A patent/MX351963B/es active IP Right Grant
- 2014-03-06 BR BR112015022600A patent/BR112015022600A2/pt active Search and Examination
- 2014-03-06 GE GEAP201413956A patent/GEP201706779B/en unknown
- 2014-03-06 TW TW103107729A patent/TWI627165B/zh not_active IP Right Cessation
- 2014-03-06 US US14/198,975 patent/US9139542B2/en active Active
- 2014-03-06 CN CN201480013807.7A patent/CN105121417B/zh active Active
- 2014-03-06 KR KR1020157026105A patent/KR20150126368A/ko not_active Application Discontinuation
- 2014-03-06 WO PCT/US2014/021080 patent/WO2014164187A1/en active Application Filing
- 2014-03-06 AU AU2014249611A patent/AU2014249611B2/en not_active Ceased
- 2014-03-06 MD MDA20150099A patent/MD4719C1/ro active IP Right Grant
- 2014-03-06 UA UAA201509929A patent/UA115087C2/uk unknown
-
2015
- 2015-08-17 IL IL240600A patent/IL240600A0/en unknown
- 2015-09-11 PH PH12015502067A patent/PH12015502067A1/en unknown
-
2016
- 2016-03-07 HK HK16102556.4A patent/HK1214596A1/zh not_active IP Right Cessation
-
2018
- 2018-08-15 JP JP2018152961A patent/JP2018197256A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CN105121417A (zh) | 2015-12-02 |
| AU2014249611B2 (en) | 2017-12-21 |
| SG11201507221VA (en) | 2015-10-29 |
| EP2970164A1 (en) | 2016-01-20 |
| WO2014164187A1 (en) | 2014-10-09 |
| MX2015012146A (es) | 2015-11-25 |
| CN105121417B (zh) | 2017-11-17 |
| EA027911B1 (ru) | 2017-09-29 |
| US20140275554A1 (en) | 2014-09-18 |
| TWI627165B (zh) | 2018-06-21 |
| MX351963B (es) | 2017-11-06 |
| US9139542B2 (en) | 2015-09-22 |
| ES2634019T3 (es) | 2017-09-26 |
| UA115087C2 (uk) | 2017-09-11 |
| MD4719B1 (ro) | 2020-10-31 |
| BR112015022600A2 (pt) | 2017-07-18 |
| JP2018197256A (ja) | 2018-12-13 |
| CA2902724A1 (en) | 2014-10-09 |
| MD4719C1 (ro) | 2021-05-31 |
| MD20150099A2 (ro) | 2016-02-29 |
| EA201591708A1 (ru) | 2016-01-29 |
| JP6404309B2 (ja) | 2018-10-10 |
| TW201444810A (zh) | 2014-12-01 |
| GEP201706779B (en) | 2017-11-27 |
| EP2970164B1 (en) | 2017-05-03 |
| AU2014249611A1 (en) | 2015-09-17 |
| JP2016512257A (ja) | 2016-04-25 |
| IL240600A0 (en) | 2015-09-24 |
| PH12015502067B1 (en) | 2016-01-25 |
| KR20150126368A (ko) | 2015-11-11 |
| PH12015502067A1 (en) | 2016-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1224226A1 (zh) | 與間水楊酸形成的烟鹼鹽 | |
| IL245865B (en) | Form i of crystalline ibrutinib | |
| HK1222334A1 (zh) | 抗病毒索非布韋類似物的晶型 | |
| EP2970081A4 (en) | SALTS OF TREPROSTINIL | |
| PL3008039T3 (pl) | Krystaliczna postać inhibitora mdm2 | |
| EP2863918A4 (en) | SALT CRYSTALS | |
| RU2016118399A3 (en) | 4-aminomethylbenzoic acid derivative | |
| HK1217331A1 (zh) | }- -氰基- -氯苯氧基 -羥基-異喹啉- -羰基 -氨基}-乙酸的晶型 | |
| PT2975022T (pt) | Novo derivado de ácido hidroxâmico ou um seu sal | |
| HK1220187A1 (zh) | 抗焦慮化合物的晶型 | |
| GB2519787B (en) | Process for the preparation of herbicidal carboxylic acid salts | |
| HK1220458A1 (zh) | 化合物之多晶型物及鹽 | |
| HK1200454A1 (zh) | 琥珀酸鹽的晶形 | |
| EP3021849A4 (en) | Novel crystalline forms of pemetrexed tromethamine salts | |
| EP2977459A4 (en) | PROCESS FOR THE PREPARATION OF 5-AMINOLÄVULINIC ACID OR A SALT THEREOF | |
| HK1214596A1 (zh) | 經取代噻唑基乙酸三乙胺鹽的結晶型 | |
| EP2970188A4 (en) | NOVEL CRYSTALLINE FORMS | |
| GB201300903D0 (en) | Crystalline Form | |
| SG11201509307VA (en) | Crystalline forms of zinc trisodium pentetic acid | |
| GB201322785D0 (en) | Manufacture of lactic acid | |
| AU2013903615A0 (en) | Process for preparation of herbicidal salts | |
| TH1401007860A (th) | สารประกอบไดเมธิล-เบนโซอิค แอซิด |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20220302 |